Drug intelligence / Profile preview

hericium erinaceus (Jiangsu Shenhua Pharmaceutical)

Development stage
Unknown
Lead developer
Shenghua Pharmaceutical Technology
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Hericium mushroom, specifically referring to the extract of the fungus *Hericium erinaceus* (Lion's Mane), is an approved pharmaceutical product in China, commonly marketed as Houtoujun tablets (猴头菌片). Developed and manufactured by companies such as Shenghua Pharmaceutical Technology, it is primarily indicated for the treatment of gastrointestinal conditions, including chronic gastritis, gastric ulcers, and duodenal ulcers. The therapeutic effect is attributed to its ability to protect and promote the repair of the gastric mucosa, reduce inflammation, and potentially inhibit the growth of *Helicobacter pylori*. Beyond its gastrointestinal applications, *Hericium erinaceus* contains bioactive compounds like hericenones and erinacines that stimulate the synthesis of nerve growth factor (NGF), leading to significant research interest in its neuroprotective and cognitive-enhancing properties.

Brand names
Houtoujun Pian
Other names
Hericium mushroomLion's Mane mushroomHoutoujun猴头菌片

Beyond the preview

Go deeper on hericium erinaceus (Jiangsu Shenhua Pharmaceutical).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hericium erinaceus (Jiangsu Shenhua Pharmaceutical).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call